CD133 expression in circulating tumor cells from breast cancer patients: potential role in resistance to chemotherapy (Q39153898)

9 September 2017

title

CD133 expression in circulating tumor cells from breast cancer patients: potential role in resistance to chemotherapy (English)

1 reference

9 September 2017

1 reference

Jose A Lorente

4

0 references

author name string

Rosa Nadal

1

1 reference

9 September 2017

F Gabriel Ortega

2

1 reference

9 September 2017

Marta Salido

3

1 reference

9 September 2017

Maria Rodríguez-Rivera

5

1 reference

9 September 2017

Miguel Delgado-Rodríguez

6

1 reference

9 September 2017

Marta Macià

7

1 reference

9 September 2017

Ana Fernández

8

1 reference

9 September 2017

Josep M Corominas

9

1 reference

9 September 2017

J Luis García-Puche

10

1 reference

9 September 2017

Pedro Sánchez-Rovira

11

1 reference

9 September 2017

Francesc Solé

12

1 reference

9 September 2017

M Jose Serrano

13

1 reference

9 September 2017

language of work or name

English

0 references

publication date

6 July 2013

1 reference

International Journal of Cancer

9 September 2017

published in

1 reference

9 September 2017

volume

133

1 reference

9 September 2017

issue

10

1 reference

9 September 2017

page(s)

2398-2407

1 reference

Management of breast cancer with targeted agents: importance of heterogeneity. [corrected].

9 September 2017

cites work

1 reference

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

21 January 2018

1 reference

Cancer stem cells and self-renewal.

21 January 2018

1 reference

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

Generation of breast cancer stem cells through epithelial-mesenchymal transition

21 January 2018

1 reference

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial

21 January 2018

1 reference

Circulating tumour cells in non-metastatic breast cancer: a prospective study

21 January 2018

1 reference

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

21 January 2018

1 reference

Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics

21 January 2018

1 reference

Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy

21 January 2018

1 reference

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

21 January 2018

1 reference

Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.

21 January 2018

1 reference

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

21 January 2018

1 reference

Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients.

21 January 2018

1 reference

Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells

21 January 2018

1 reference

Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.

21 January 2018

1 reference

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation

21 January 2018

1 reference

The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells

21 January 2018

1 reference

Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer

21 January 2018

1 reference

Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics

21 January 2018

1 reference

CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer

21 January 2018

1 reference

Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content

21 January 2018

1 reference

IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland

21 January 2018

1 reference

Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations

21 January 2018

1 reference

CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer

21 January 2018

1 reference

Role of sonic hedgehog signaling in migration of cell lines established from CD133-positive malignant glioma cells.

21 January 2018

1 reference

Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications

21 January 2018

1 reference

CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer

21 January 2018

1 reference

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

21 January 2018

1 reference

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

21 January 2018

1 reference

Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations

21 January 2018

1 reference

Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis

21 January 2018

1 reference

Biomarkers characterization of circulating tumour cells in breast cancer patients

21 January 2018

1 reference

Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers

21 January 2018

1 reference

Mesenchymal stem cells facilitate the derivation of human embryonic stem cells from cryopreserved poor-quality embryos

21 January 2018

1 reference

Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.

21 January 2018

1 reference

Cancer stem cells in breast: current opinion and future challenges.

21 January 2018

1 reference

Heterogeneity in breast cancer

21 January 2018

1 reference

The increasing complexity of the cancer stem cell paradigm

21 January 2018

1 reference

Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry

21 January 2018

1 reference

Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood

21 January 2018

1 reference

Identification of selective inhibitors of cancer stem cells by high-throughput screening

21 January 2018

1 reference

Salinomycin selectively targets 'CD133+' cell subpopulations and decreases malignant traits in colorectal cancer lines

21 January 2018

1 reference

Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28263

1 reference

9 September 2017

1 reference